BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25895596)

  • 1. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
    Wang Z; Cui K; Xue Y; Tong F; Li S
    Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN).
    Hristozova T; Konschak R; Stromberger C; Fusi A; Liu Z; Weichert W; Stenzinger A; Budach V; Keilholz U; Tinhofer I
    Ann Oncol; 2011 Aug; 22(8):1878-85. PubMed ID: 21525401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results.
    Jatana KR; Balasubramanian P; Lang JC; Yang L; Jatana CA; White E; Agrawal A; Ozer E; Schuller DE; Teknos TN; Chalmers JJ
    Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1274-9. PubMed ID: 21173379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.
    Jatana KR; Balasubramanian P; McMullen KP; Lang JC; Teknos TN; Chalmers JJ
    Head Neck; 2016 Dec; 38(12):1799-1803. PubMed ID: 27265898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck.
    Tinhofer I; Konschak R; Stromberger C; Raguse JD; Dreyer JH; Jöhrens K; Keilholz U; Budach V
    Ann Oncol; 2014 Oct; 25(10):2042-2047. PubMed ID: 25057171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
    Nichols AC; Lowes LE; Szeto CC; Basmaji J; Dhaliwal S; Chapeskie C; Todorovic B; Read N; Venkatesan V; Hammond A; Palma DA; Winquist E; Ernst S; Fung K; Franklin JH; Yoo J; Koropatnick J; Mymryk JS; Barrett JW; Allan AL
    Head Neck; 2012 Oct; 34(10):1440-4. PubMed ID: 22076949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
    Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
    PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells in patients with head and neck squamous cell carcinoma: Feasibility of detection and quantitation.
    Kawada T; Takahashi H; Sakakura K; Ida S; Mito I; Toyoda M; Chikamatsu K
    Head Neck; 2017 Nov; 39(11):2180-2186. PubMed ID: 28815839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peripheral blood circulating tumor cells in local advanced head and neck squamous cell carcinoma].
    Lou JL; Guo L; Zheng WH; Zhao JZ; Zhao JQ; Liang Z; Wang SY; Fang MY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):824-829. PubMed ID: 29141291
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.
    Cho JK; Lee GJ; Kim HD; Moon UY; Kim MJ; Kim S; Baek KH; Jeong HS
    PLoS One; 2018; 13(9):e0203758. PubMed ID: 30192876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients.
    Zhang X; Weeramange CE; Hughes BGM; Vasani S; Liu ZY; Warkiani M; Hartel G; Ladwa R; Thiery JP; Kenny L; Breik O; Punyadeera C
    Cell Mol Life Sci; 2024 May; 81(1):233. PubMed ID: 38780775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma.
    Strati A; Koutsodontis G; Papaxoinis G; Angelidis I; Zavridou M; Economopoulou P; Kotsantis I; Avgeris M; Mazel M; Perisanidis C; Sasaki C; Alix-Panabières C; Lianidou E; Psyrri A
    Ann Oncol; 2017 Aug; 28(8):1923-1933. PubMed ID: 28838214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.
    Wu XL; Tu Q; Faure G; Gallet P; Kohler C; Bittencourt Mde C
    Sci Rep; 2016 Feb; 6():20210. PubMed ID: 26831813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck.
    Tinhofer I; Hristozova T; Stromberger C; Keilhoiz U; Budach V
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e685-90. PubMed ID: 22583603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma.
    Hsieh JC; Lin HC; Huang CY; Hsu HL; Wu TM; Lee CL; Chen MC; Wang HM; Tseng CP
    Head Neck; 2015 Oct; 37(10):1448-55. PubMed ID: 24844673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.
    Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H
    Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Xun Y; Cao Q; Zhang J; Guan B; Wang M
    Oral Oncol; 2020 May; 104():104638. PubMed ID: 32182549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.